Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Oncology Ventures is a venture capital firm founded by Ben Freeberg, a cancer survivor, dedicated to investing in healthcare data companies that address significant challenges in cancer care. Established in the United States, the firm focuses on improving early detection, ensuring guideline-based care, and enhancing the overall infrastructure of cancer treatment. Oncology Ventures aims to tackle the fragmented and costly nature of the U.S. oncology system through innovative solutions.
Currently, Oncology Ventures manages a portfolio of seven notable companies, emphasizing their commitment to transforming the oncology landscape. The firm’s approach is driven by a personal connection to cancer care, which informs their investment strategy and selection of technologies that can significantly impact patient outcomes.
Oncology Ventures invests in technologies that address various aspects of cancer care, including early detection, patient navigation, data access, and AI-powered treatment optimization. The firm specifically targets healthcare data companies that can mitigate the challenges faced by the U.S. oncology system. Their investment thesis emphasizes funding innovations that can transform the cancer care journey from diagnosis to survivorship.
Oncology Ventures seeks to partner with startups that demonstrate a clear understanding of the oncology landscape and possess the potential to improve operational efficiency and patient support. The firm looks for solutions that can enhance the overall patient experience and streamline processes within cancer treatment facilities.
Oncology Ventures has invested in a diverse range of companies that are making significant strides in cancer care. Notable portfolio companies include:
These companies exemplify Oncology Ventures' commitment to funding innovations that can significantly impact the oncology landscape and improve patient outcomes.
Ben Freeberg: Founder, Managing Partner. Ben has personal experience as a cancer survivor, which informs his investment strategy and focus on healthcare data solutions.
Nandita Kotwani: Venture Associate. Nandita supports the investment team in evaluating potential portfolio companies and conducting market research.
Khail Macadaeg: Executive Assistant. Khail provides administrative support to the team, ensuring smooth operations within the firm.
Jay Freeberg, CPA, CFP, MBA: Chief Financial Officer. Jay oversees the financial operations of the firm, bringing expertise in finance and investment management.
Sebastian Rositano, MBBS MPH: Venture Partner. Sebastian contributes his medical and public health expertise to evaluate healthcare-related investments.
Ethan Zohn: Venture Partner. Ethan brings experience in entrepreneurship and investment to the firm, focusing on healthcare innovations.
To pitch to Oncology Ventures, founders should visit their website at oncology.ventures. It is recommended to include a comprehensive deck that outlines the technology, market opportunity, and team qualifications. The firm does not specify a response time, but a well-prepared pitch is essential for consideration.
Oncology Ventures has been actively investing in healthcare data companies that address significant challenges in cancer care. Their portfolio currently includes seven notable companies, each focused on improving various aspects of oncology.
Recent investments include companies like mPATH, which enhances access to lung cancer screenings, and Tono, which helps patients manage treatment side effects. These investments reflect Oncology Ventures' commitment to transforming the cancer care journey through innovative technologies.
What are Oncology Ventures' investment criteria?
Oncology Ventures focuses on healthcare data companies that address significant challenges in cancer care, particularly those that improve early detection, patient navigation, and treatment optimization through technology.
How can I apply or pitch to Oncology Ventures?
Founders can submit their pitches through the Oncology Ventures website at oncology.ventures. It is advisable to include detailed information about the technology, market potential, and team background in the pitch.
What makes Oncology Ventures different from other venture capital firms?
The firm is founded by Ben Freeberg, a cancer survivor, which provides a unique perspective on the challenges faced in cancer care. This personal connection drives their commitment to funding impactful solutions in the oncology space.
What is the geographic scope of Oncology Ventures' investments?
Oncology Ventures primarily invests in companies based in the United States, focusing on innovations that can improve the U.S. oncology system.
What is the typical check size for investments?
While specific check sizes are not disclosed, Oncology Ventures targets healthcare data companies at various stages of development, indicating a flexible investment approach.
What type of post-investment involvement does Oncology Ventures have?
The firm actively supports its portfolio companies by providing operational guidance, strategic advice, and access to their network within the healthcare industry.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.